Recently, Guo et al. found that miR-410 acts as a TSmiR which suppresses pancreatic cancer growth, cell invasion, migration and angiogenesis by targeting angiotensin II type 1 receptor (AGTR1) [78]. Here, AGTR1 is linked to familial pancreatic carcinoma.